Forty-three out of 58 GBM patients (74%) examined so far in our database display positive AR expression in >10% tumor cell nuclei, with the other eleven patients showing 1–10% positivity (93% with >1% positivity) and only four patients’ tumor were found to be completely devoid of AR staining. This evidence concerns the gene AR and neoplasm.